‹ Library
5-Amino-1MQ
Mitochondrial & MetabolicResearch Use Only
Also known as: 5-amino-1-methylquinolinium, NNMT inhibitor
5-Amino-1MQ is a small-molecule research compound commonly referenced in metabolic research literature as an inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT). Studies describe interest in NNMT inhibition in relation to cellular NAD+ handling and adipocyte metabolism. It is a research compound rather than an approved therapeutic.
Typical range (research)
Research literature references vary; commonly cited oral reference points fall in the ~50–150 mg/day range
Half-life
Not well established in published human data
Route
Oral (research)
Common use
Metabolic enzyme (NNMT) research
Common vial sizes
10 mg · 50 mg
Storage
Store powder in a cool, dry place protected from light; if in solution, keep refrigerated and use within the timeframe supported by stability data.
Stacking notes
Sometimes referenced alongside NAD+ precursors in research discussions on cellular NAD+ metabolism; combinations are not well characterized.
Reported side effects
Limited human safety dataGenerally reported as well tolerated in preclinical studies
Regulatory note: Not approved as a therapeutic drug in Canada or the US; research compound. Research-grade material is not for human use.
Calculate a dose →Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Not for human or veterinary use. Consult a licensed physician.